Brief: Vivos Inc. Files Early Feasibility Ide Application With FDA For Radiogel™
20/09/2021 17:48
Sept 20 (Reuters) - Vivos Inc RDGL.PK :
* VIVOS INC. FILES EARLY FEASIBILITY IDE APPLICATION WITH
FDA FOR
RADIOGEL™
* VIVOS INC - FDA RECOMMENDED PATH TO FACILITATE ENHANCED
ONGOING
COMMUNICATION WITH VIVOS AND TO INCREASE EFFICIENCY OF REVIEW
PROCESS
Source text for Eikon: urn:newsml:reuters.com:*:nGNX76J16F
Further company coverage: RDGL.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos
See all newsBrief: Vivos Inc. Announces Progress Toward FDA Investigational Device Exemption (Ide) Submission
Brief: Vivos Inc. Strengthens Strategic Collaboration With Exubrion Therapeutics
Brief: Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., To Support Ide Submission For Radiogel®
Brief: Vivos Board Authorizes To Establish A Corporate Entity In India
Brief: Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025